Wegovy belongs to a class of medicines called GLP-1 receptor agonists, which were originally developed to help manage blood sugar levels in people with type 2 diabetes
Meier, [email protected] This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Ozempic's therapeutic effect depends on systemic absorption and action on GLP-1 receptors throughout the body, not on local tissue reactions at the injection site
10.1136/bmjdrc-2020-001706 38
Learning about insulin needle gauge sizes helps you select comfortable needles for your injections
For the scenario of "Proven Treatment Today," research data suggests Semaglutide may be more relevant